Table 1. Complete blood count: Values are expressed as mean ± SD (n = 8).
| Parameters | Group I | Group II | Group III | Group IV |
|---|---|---|---|---|
| PVC | 39.33 ± 0.67 | 35.20 ± 1.93 | 37.25 ± 3.04 | 33.75 ± 0.25 |
| White blood cells (10 m/m3) | 6500 ± 288.68 | 6100 ± 556.78 | 6500 ± 540.06 | 5000 ± 204.12 |
| Lymphocytes | 18.23 ± 1.76 | 20.00 ± 0.50* | 20.40 ± 0.58 | 20.00 ± 0.82 |
| Neutrophils | 81.67 ± 1.76 | 78.20 ± 0.58* | 79.50 ± 0.96 | 79.00 ± 0.86 |
| Hb (g/dl) | 8.10 ± 0.29 | 6.07 ± 0.18 | 6.93 ± 0.26 | 7.10 ± 0.70 |
| MCV(μm3) | 72.9 ± 7.97 | 133.4 ± 23 | 105.7 ± 15.6 | 88.0 ± 10.2 |
| MCH (pg) | 20.9 ± 2.21 | 31.1 ± 4.37 | 26.7 ± 4.04 | 22.7 ± 1.75 |
| MCHC (%) | 29.1 ± 1.88 | 24.1 ± 1.74 | 25.9 ± 2.31 | 26.7 ± 1.98 |
| RBC (106 /mm3) | 8.67 ± 0.072 | 6.40 ± 0.092* | 7.47 ± 0.0821** | 8.52 ± 0.079 |
Group I: Normal control treated with saline (0.9%); Group II: Hepatotoxic control group treated with acetaminophen (750 mg/kg body weight); Group III: Treated with FEO (250 mg/kg body weight) and acetaminophen (750 mg/kg body weight); Group IV: Treated with FEO (500 mg/kg body weight) and acetaminophen (750 mg/kg body weight). *Represents significant difference at P < 0.05 compared with control. **Represents significant difference at P < 0.01 compared with hepatotoxic control group.